Use the Search Fields to Find Information
Page 99 of 373
Photoprotective Effects of Cannabidiol against Ultraviolet-B-Induced DNA Damage and Autophagy in Human Keratinocyte Cells and Mouse Skin Tissue
Abstract Cannabidiol (CBD) has emerged as a phytocannabinoid with various beneficial effects for the skin, including anti-photoaging effects, but its mechanisms of action are not
January 17, 2024
Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)
Please use this link to access this publication. Abstract Purpose To determine whether cannabidiol (CBD) oil can improve symptom distress in patients with advanced cancer
October 3, 2024
Pharmacovigilance in the Age of Legalized Cannabis: Using Social Media to Monitor Drug–Drug Interactions Between Immunosuppressants and Cannabis-Derived Products
Please use this link to access this publication. Abstract Introduction A clinical trial of Epidiolex®, the only US FDA-approved cannabis-derived consumer product (CDP), discovered an
May 3, 2025
Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis
Please use this link to access this publication. Abstract Objective This study aimed to determine the efficacy and acceptability of pharmacotherapies for cannabis use disorder
October 12, 2025
Pharmacotherapies for cannabis use disorder
Please use this link to access this publication. ABSTRACT Rationale Globally, cannabis use is prevalent and widespread. There are currently no pharmacotherapies approved for the
November 20, 2025
Pharmacology of Non-Psychoactive Phytocannabinoids and Their Potential for Treatment of Cardiometabolic Disease
Please use this link to access this publication. Abstract The use of Cannabis sativa by humans dates back to the third millennium BC, and it has been
March 7, 2026
Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin
Abstract Background: In addition to the major phytocannabinoids, trans-Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD), the cannabis plant (Cannabis sativa L.) synthesizes over 120 additional cannabinoids that are known
February 28, 2024
Pharmacology and drug interactions of cannabinoids
ABSTRACT Cannabinoids include a variety of substances, of which cannabidiol (CBD) is the main substance investigated for the treatment of epilepsy, and this will be
September 25, 2025
Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview
Please use this link to access this publication. Abstract Marijuana, or Cannabis sativa L., is a common psychoactive plant used for both recreational and medicinal purposes. In
May 17, 2025
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
Please use this link to access this publication. Abstract Background Recent approved medicines whose active principles are Δ9Tetrahidrocannabinol (Δ9-THC) and/or cannabidiol (CBD) open novel perspectives for other
September 5, 2025
Page 99 of 373